Immunitybio Inc (IBRX)

Other Income/Expenses (Net)

-$168.69M

Quarterly · Period ending: · USD

IBRX logo

IBRX Other Income/Expenses (Net)

Latest reported-$168.69M
IBRX Quarterly Other Income/Expenses (Net) (-$498.00K → -$168.69M)
High-resolution chart · PNG

IBRX other income/expenses (net) history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Immunitybio Inc Other Income/Expenses (Net) — Quarterly (USD)
Period endingOther Income/Expenses (Net) (USD)
-168,693,000
-563,000,000
2,590,000
-11,679,000
-21,020,000
-65,471,000
10,221,000
-5,499,000
-35,251,000
-38,934,000
-148,065,000
-15,506,000
-53,068,000
-5,003,000
-24,073,000
-20,357,000
-15,213,000
-7,026,000
-12,278,000
-9,593,000
-3,477,000
5,789,000
-1,247,000
-1,993,000
-1,056,000
-707,000
-1,660,000
484,000
616,000
-3,000
-145,000
345,000
-106,000
641,000
735,000
-393,000
244,000
-37,000
757,000
-29,000
740,000
796,000
0
145,000
-498,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.